Research News

The Center for Cardiovascular Diseases and Sciences works throughout the year to advance cardiovascular research

Shreveport Times - Dr. Wayne Orr, Professor and Director of the Center for Cardiovascular Diseases and Sciences said, "the Center is a group of faculty members across multiple departments who work together to build a nationally competitive research group here in Shreveport."

Read More about The Center for Cardiovascular Diseases and Sciences works throughout the year to advance cardiovascular research (opens in new window/tab)
Data Hint COVID-19 Vax May Improve Immunotherapy Efficacy in Some

Medscape - Alexandre Malek, MD, assistant professor of medicine at LSUHS, pointed to "a growing number of preclinical studies evaluating the role of vaccines as adjunct to immunotherapy to overcome cancer resistance by converting cold tumors to hot." That research includes a study of a seasonal influenza vaccine and another of adenoviral based-vaccines.

Read More about Data Hint COVID-19 Vax May Improve Immunotherapy Efficacy in Some (opens in new window/tab)
LSUHS LARC hosts meeting on the threat of Methamphetamine use in Northwest Louisiana

LSUHS Louisiana Addiction Research Center hosted a meeting on Wednesday, Nov. 9, to discuss methamphetamine as an emerging drug threat in our region. Local law enforcement and community leaders were invited to have an open conversation and share information on drug problems in the region and determine how to raise awareness.

Read More about LSUHS LARC hosts meeting on the threat of Methamphetamine use in Northwest Louisiana
man looking through microscope in laboratory

Dr. Chris Kevil’s laboratory at LSUHS has discovered that a clinically approved cyclodextrin-based drug called Sugammadex can act as a hydrogen sulfide donor that restores vasoactive hydrogen. This innovation has already gone through initial in vivo testing with promising results.

Read More about LSU Health Shreveport and CarboHyde collaborate to develop cyclodextrins for restoring sulfide in various disease conditions
LSUHS and LSUS use AI to treat Cavernous Malformations

“Medicine in general is considerably complex and neurosurgery is extremely complex, with cavernous malformations among the most difficult to manage,” said Dr. Caleb Stewart, neurosurgeon at LSUHS. LSUHS, LSUS, Ochsner Health, and collaborators in Australia are now leveraging big data science and artificial intelligence (AI) to solve this challenge and improve care for patients.

Read More about LSUHS and LSUS use AI to treat Cavernous Malformations (opens in new window/tab)